Literature DB >> 22010916

Inflammatory skin and bowel disease linked to ADAM17 deletion.

Diana C Blaydon1, Paolo Biancheri, Wei-Li Di, Vincent Plagnol, Rita M Cabral, Matthew A Brooke, David A van Heel, Franz Ruschendorf, Mark Toynbee, Amanda Walne, Edel A O'Toole, Joanne E Martin, Keith Lindley, Tom Vulliamy, Dominic J Abrams, Thomas T MacDonald, John I Harper, David P Kelsell.   

Abstract

We performed genetic and immunohistochemical studies in a sister and brother with autosomal recessive neonatal inflammatory skin and bowel lesions. The girl died suddenly at 12 years of age from parvovirus B19-associated myocarditis; her brother had mild cardiomyopathy. We identified a loss-of-function mutation in ADAM17, which encodes a disintegrin and metalloproteinase 17 (also called tumor necrosis factor α [TNF-α]-converting enzyme, or TACE), as the probable cause of this syndrome. Peripheral-blood mononuclear cells (PBMCs) obtained from the brother at 17 years of age showed high levels of lipopolysaccharide-induced production of interleukin-1β and interleukin-6 but impaired release of TNF-α. Despite repeated skin infections, this young man has led a relatively normal life. (Funded by Barts and the London Charity and the European Commission Seventh Framework Programme.).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22010916     DOI: 10.1056/NEJMoa1100721

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  124 in total

Review 1.  ADAM Proteases and Gastrointestinal Function.

Authors:  Jennifer C Jones; Shelly Rustagi; Peter J Dempsey
Journal:  Annu Rev Physiol       Date:  2015-11-19       Impact factor: 19.318

Review 2.  Metalloproteinases and their natural inhibitors in inflammation and immunity.

Authors:  Rama Khokha; Aditya Murthy; Ashley Weiss
Journal:  Nat Rev Immunol       Date:  2013-09       Impact factor: 53.106

3.  Dysbiosis and Staphylococcus aureus Colonization Drives Inflammation in Atopic Dermatitis.

Authors:  Tetsuro Kobayashi; Martin Glatz; Keisuke Horiuchi; Hiroshi Kawasaki; Haruhiko Akiyama; Daniel H Kaplan; Heidi H Kong; Masayuki Amagai; Keisuke Nagao
Journal:  Immunity       Date:  2015-04-21       Impact factor: 31.745

4.  Interleukin-15 receptor α expression in inflammatory bowel disease patients before and after normalization of inflammation with infliximab.

Authors:  Clémentine Perrier; Ingrid Arijs; Dominiek Staelens; Christine Breynaert; Isabelle Cleynen; Kris Covens; Marc Ferrante; Gert Van Assche; Séverine Vermeire; Gert de Hertogh; Frans Schuit; Paul Rutgeerts; Jan L Ceuppens
Journal:  Immunology       Date:  2013-01       Impact factor: 7.397

5.  Exome sequencing finds a novel PCSK1 mutation in a child with generalized malabsorptive diarrhea and diabetes insipidus.

Authors:  Michael Yourshaw; R Sergio Solorzano-Vargas; Lindsay A Pickett; Iris Lindberg; Jiafang Wang; Galen Cortina; Anna Pawlikowska-Haddal; Howard Baron; Robert S Venick; Stanley F Nelson; Martín G Martín
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-12       Impact factor: 2.839

6.  Genetic variants of Adam17 differentially regulate TGFβ signaling to modify vascular pathology in mice and humans.

Authors:  Kyoko Kawasaki; Julia Freimuth; Dominique S Meyer; Marie M Lee; Akiko Tochimoto-Okamoto; Michael Benzinou; Frederic F Clermont; Gloria Wu; Ritu Roy; Tom G W Letteboer; Johannes Kristian Ploos van Amstel; Sophie Giraud; Sophie Dupuis-Girod; Gaeten Lesca; Cornelius J J Westermann; Robert J Coffey; Rosemary J Akhurst
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-08       Impact factor: 11.205

7.  A Lactobacillus rhamnosus GG-derived soluble protein, p40, stimulates ligand release from intestinal epithelial cells to transactivate epidermal growth factor receptor.

Authors:  Fang Yan; Liping Liu; Peter J Dempsey; Yu-Hwai Tsai; Elaine W Raines; Carole L Wilson; Hailong Cao; Zheng Cao; LinShu Liu; D Brent Polk
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

8.  iRhoms 1 and 2 are essential upstream regulators of ADAM17-dependent EGFR signaling.

Authors:  Xue Li; Thorsten Maretzky; Gisela Weskamp; Sébastien Monette; Xiaoping Qing; Priya Darshinee A Issuree; Howard C Crawford; David R McIlwain; Tak W Mak; Jane E Salmon; Carl P Blobel
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

9.  ADAM17 stabilizes its interacting partner inactive Rhomboid 2 (iRhom2) but not inactive Rhomboid 1 (iRhom1).

Authors:  Gisela Weskamp; Johanna Tüshaus; Daniel Li; Regina Feederle; Thorsten Maretzky; Steven Swendemann; Erik Falck-Pedersen; David R McIlwain; Tak W Mak; Jane E Salmon; Stefan F Lichtenthaler; Carl P Blobel
Journal:  J Biol Chem       Date:  2020-02-14       Impact factor: 5.157

10.  Loss of ADAM17-Mediated Tumor Necrosis Factor Alpha Signaling in Intestinal Cells Attenuates Mucosal Atrophy in a Mouse Model of Parenteral Nutrition.

Authors:  Yongjia Feng; Yu-Hwai Tsai; Weidong Xiao; Matthew W Ralls; Alex Stoeck; Carole L Wilson; Elaine W Raines; Daniel H Teitelbaum; Peter J Dempsey
Journal:  Mol Cell Biol       Date:  2015-08-17       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.